Suppr超能文献

相似文献

1
T cell factor 1: A master regulator of the T cell response in disease.
Sci Immunol. 2020 Nov 6;5(53). doi: 10.1126/sciimmunol.abb9726.
2
The Transcription Factor TCF1 in T Cell Differentiation and Aging.
Int J Mol Sci. 2020 Sep 5;21(18):6497. doi: 10.3390/ijms21186497.
3
Central memory CD8 T cells derive from stem-like Tcf7 effector cells in the absence of cytotoxic differentiation.
Immunity. 2020 Nov 17;53(5):985-1000.e11. doi: 10.1016/j.immuni.2020.09.005. Epub 2020 Oct 30.
4
Regulation of immune responses by E3 ubiquitin ligase Cbl-b.
Cell Immunol. 2019 Jun;340:103878. doi: 10.1016/j.cellimm.2018.11.002. Epub 2018 Nov 7.
5
TCF1 and beta-catenin regulate T cell development and function.
Immunol Res. 2010 Jul;47(1-3):45-55. doi: 10.1007/s12026-009-8137-2.
6
Suppression of Tcf1 by Inflammatory Cytokines Facilitates Effector CD8 T Cell Differentiation.
Cell Rep. 2018 Feb 20;22(8):2107-2117. doi: 10.1016/j.celrep.2018.01.072.
7
T Cell Factor 1 Suppresses CD103+ Lung Tissue-Resident Memory T Cell Development.
Cell Rep. 2020 Apr 7;31(1):107484. doi: 10.1016/j.celrep.2020.03.048.
8
Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
Mol Aspects Med. 2012 Feb;33(1):107-18. doi: 10.1016/j.mam.2011.10.001. Epub 2011 Oct 14.
9
Therapeutic utility of the newly discovered properties of interleukin-21.
Cytokine. 2016 Jun;82:33-7. doi: 10.1016/j.cyto.2015.12.018. Epub 2015 Dec 31.
10
T cell proliferation and homeostasis: an emerging role for the cell cycle inhibitor geminin.
Crit Rev Immunol. 2011;31(3):209-31. doi: 10.1615/critrevimmunol.v31.i3.30.

引用本文的文献

1
Immune Profiling among Colorectal Cancer Subtypes using Dependent Mixture Models.
J Am Stat Assoc. 2025;120(550):671-684. doi: 10.1080/01621459.2024.2427936. Epub 2025 Feb 25.
3
Early-life human CD8 T cells exhibit rapid, short-lived effector responses and a unique transcription factor landscape.
Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2421106122. doi: 10.1073/pnas.2421106122. Epub 2025 Jul 28.
5
Membrane-bound IL-15 co-expression powers a potent and persistent CD70-targeted TRuC T-cell therapy.
Front Immunol. 2025 May 30;16:1609658. doi: 10.3389/fimmu.2025.1609658. eCollection 2025.
6
Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes.
Nat Commun. 2025 May 30;16(1):5033. doi: 10.1038/s41467-025-60276-5.
9
IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models.
J Clin Invest. 2025 Apr 17;135(12). doi: 10.1172/JCI181471. eCollection 2025 Jun 16.
10
The diversity of CD8 T cell dysfunction in cancer and viral infection.
Nat Rev Immunol. 2025 Apr 11. doi: 10.1038/s41577-025-01161-6.

本文引用的文献

1
Early precursor T cells establish and propagate T cell exhaustion in chronic infection.
Nat Immunol. 2020 Oct;21(10):1256-1266. doi: 10.1038/s41590-020-0760-z. Epub 2020 Aug 24.
3
Ectopic Tcf1 expression instills a stem-like program in exhausted CD8 T cells to enhance viral and tumor immunity.
Cell Mol Immunol. 2021 May;18(5):1262-1277. doi: 10.1038/s41423-020-0436-5. Epub 2020 Apr 27.
4
T Cell Factor 1 Suppresses CD103+ Lung Tissue-Resident Memory T Cell Development.
Cell Rep. 2020 Apr 7;31(1):107484. doi: 10.1016/j.celrep.2020.03.048.
5
CD8 T cell states in human cancer: insights from single-cell analysis.
Nat Rev Cancer. 2020 Apr;20(4):218-232. doi: 10.1038/s41568-019-0235-4. Epub 2020 Feb 5.
6
B cells are associated with survival and immunotherapy response in sarcoma.
Nature. 2020 Jan;577(7791):556-560. doi: 10.1038/s41586-019-1906-8. Epub 2020 Jan 15.
7
B cells and tertiary lymphoid structures promote immunotherapy response.
Nature. 2020 Jan;577(7791):549-555. doi: 10.1038/s41586-019-1922-8. Epub 2020 Jan 15.
8
Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Nature. 2020 Jan;577(7791):561-565. doi: 10.1038/s41586-019-1914-8. Epub 2020 Jan 15.
9
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Nature. 2019 Dec;576(7787):465-470. doi: 10.1038/s41586-019-1836-5. Epub 2019 Dec 11.
10
CD4 T Cell Help Is Required for the Formation of a Cytolytic CD8 T Cell Subset that Protects against Chronic Infection and Cancer.
Immunity. 2019 Dec 17;51(6):1028-1042.e4. doi: 10.1016/j.immuni.2019.10.009. Epub 2019 Dec 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验